News By Tag
News By Place
Scientific Validation of Ozics Technology in Osteoporotic Bone
"Biomechanical evaluation of bone screw fixation with a novel bone cement" has been published on BioMedical Engineering OnLine confirming the good biomechanical screw augmentation properties of Ozics' lead product CompO6™ in osteoporotic bone.
By: Ozics Holdings, Ltd.
Ozics Holdings, Ltd. (www.ozicsholdings.com)
The complete article can be found at: http://www.biomedical-
CEO Auvo Kaikkonen stated, “ We are very pleased with this validation of our technology in one of our key surgical indications, i.e. screw augmentation. This is very important as our products are primarily intended to be used in patients with fragility fractures. The surgeons using CompO6™ for screw augmentation can now refer to measurable values when assessing whether or not to improve the purchase of the screws in a clinical procedure involving osteoporotic bone."
Ozics was founded to develop and commercialize novel, high-strength, injectable, biocomposites to improve the treatment of fragility fractures. Through collaborative partnerships, technology licensing, and internal research and development efforts, Ozics delivers innovative products that are less invasive, improve patient outcomes, and lower the cost of caring for patients with fragility fractures.
Ozics Holdings, Ltd
Auvo Kaikkonen, President, Director
tel. +1441 292 7979
--- End ---
Ozics Holdings, Ltd , Auvo Kaikkonen, President